Cronobacter species are foodborne pathogens that can affect the human central nervous system. Survivors of Cronobacter infections often suffer from severe neurological impairments, including hydrocephalus, quadriplegia, and developmental delays in all ages, especially in infants and the immunocompromised. Moreover, Cronobacter species pose a high risk in powdered infant formula (PIF) because PIF is a major source of nutrition for infants worldwide. To develop a rapid and sensitive detection method for Cronobacter species in PIF, immunoliposomes and immunomagnetic nanoparticles were synthesized, after which an immunoliposome-based immunomagnetic concentration and separation assay was developed and applied to PIF for the detection of Cronobacter species. The detection limits of the developed assay were 5.9 Â 10 3 ± 0.7e4.8 Â 10 4 ± 0.2 CFU/mL for Cronobacter species in pure culture with no cross-reactivity with 13 other tested non-Cronobacter strains. Additionally, the developed assay could provide results in 3 h when the contaminated level was higher than 10 4 CFU/25 g PIF and in 9 h when the contaminated level was 10 CFU/25 g PIF. The developed immunoliposome-based immunomagnetic concentration and separation assay is rapid, sensitive, and simple and thus has great potential for use in the detection of Cronobacter species in PIF.
Introduction
Cronobacter species belong a newly classified genus, Cronobacter genus, that was recently transferred from Enterobacter. There are currently 7 species of Cronobacter; namely, Cronobacter sakazakii, Cronobacter malonaticus, Cronobacter turicensis, Cronobacter muytjensii, Cronobacter dublinensis with 3 subspecies, dublinensis, lausannensis, and lactaridi, Cronobacter condimenti, and Cronobacter universalis (Iversen and Forsythe, 2003; Iversen et al., 2008; Joseph et al., 2012; Jackson et al., 2014) . Cronobacter species have been linked to life-threatening infection such as meningitis, enterocolitis, and septicemia in neonates and infants (Iversen et al., 2008) . Cronobacter species have been detected frequently in various foods, including dry powdered food, agricultural products, and fresh-cut food (Lee et al., 2010 (Lee et al., , 2012 Holy and Forsythe, 2014) . Especially, Cronobacter sakazakii, Cronobacter malonaticus, and Cronobacter turicensis have been isolated from infected neonates; however, all species of Cronobacter should be considered pathogenic because they have all been linked retrospectively to clinical cases of infection in infants or adults (Food and Agriculture Organization/World Health Organization, 2004 , 2006 , 2007 Xu et al., 2014) . It is reported that powdered infant formula (PIF) is the major source of contaminants of Cronobacter species (Cahill et al., 2008) , therefore, methods for new, rapid, and sensitive detection of Cronobacter species are urgently required to prevent its contamination in the food industry, especially in PIF.
A number of methods for the detection of Cronobacter species have been reported. According to the Korean Food Code of the Ministry of Food and Drug Safety (Ministry of Food and Drug Safety, 2005) , isolating and confirming Cronobacter sakazakii from PIF involves a pre-enrichment step in buffered peptone water (BPW), selective enrichment by Enterobacteriaceae enrichment broth, selective differential plating on violet red bile glucose agar, and biochemical confirmation of the isolated colony, which requires 5e7 days. A revised method by the United States Food and Drug Administration (2012) includes real-time polymerase chain reaction (PCR) with an internal amplification control, which needs 2e3 days to detect the Cronobacter species in PIF. Lampel and Chen (2009) described a method for isolation and detection of Cronobacter species from PIF by using chromogenic agars and a real-time PCR-based assay. In their study, the suspended cells were isolated from selective media after enrichment in BPW and confirmed by real-time PCR assay (Lampel and Chen, 2009) . Mullane et al. (2006) developed a method using a cationic-magnetic-bead to capture the Cronobacter cells, while subsequent identification was conducted after plating the captured cells onto Druggan-Forsythe-Iversen formulation agar, which can detect 1e5 colony forming unit (CFU)/500 g PIF within 24 h. Blazkova et al. (2011) reported a method in which DNA isolated from culture was used for genus Cronobacter-specific PCR with labeled primers, after which the obtained amplicons were applied to an immunochromatographic strip with a carbon-neutravidin conjugation. Zimmermann et al. (2014) reported a PCR-based detection system for Cronobacter species, including enrichment, DNA-isolation, and detection by real-time PCR, using the outer membrane protein gene ompA as a target.
Immunological methods have been widely applied for the determination of foodborne pathogens because they require less assay time than traditional culture techniques and have high specificity toward the target pathogen (Velusamy et al., 2010) . Liposome, an artificial particle, composed of phospholipids encapsulating a volume of aqueous compounds, has been successfully applied in immunoassays and biosensors (Diaz-Gonzalez et al., 2005; Jesorka and Orwar, 2008) . We previously reported a fluorescence-based liposome immunoassay using liposomes tagged with developed antibodies for easy and rapid detection of , 2006; Jans et al., 2009; Shukla et al., 2016a Shukla et al., , 2016b ). The present study was conducted to develop an easy, simple, and rapid method for the detection of 7 Cronobacter species. To accomplish this object, an antibody against 7 Cronobacter species was developed and applied into an immunomagnetic nanoparticle and immunoliposome.
Materials and methods

Bacterial strains and reagents
The bacterial strains used in this study were purchased from the NB, bactopeptone, and skim milk were purchased from Difco (Franklin Lakes, NJ, USA). Phosphatase-labeled goat anti-rabbit immunoglobulin (IgG) was purchased from Kirkegaard & Perry Laboratories, Inc. (Gaithersburg, MD, USA). PIF used for the food test was purchased from a local market in Gyeongsan-si, Republic of Korea.
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE), and 1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol (DPPG) were purchased from Avanti Polar Lipids (Alabaster, AL, USA). Cholesterol, tris(hydroxymethyl)aminomethane (Tris), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), n-octyl-b-D-glucopyranoside (OG), potassium phosphate dibasic, potassium phosphate monobasic, sucrose, Tween 20, and sodium chloride were purchased from Sigma (St. Louis, MO, USA). N-Succinimidyl-s-acetylthioacetate (SATA) and sulforhodamine B (SRB) were purchased from Pierce (Rockford, MD, USA). Carboxyl magnetic iron oxide nanoparticles conjugation kits, containing carboxyl magnetic iron oxide nanoparticles, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDAC), and N-hydroxysuccinimide (NHS), were purchased from Ocean Nano Tech (Springdale, AR, USA). Ninetysix-well microtiter plate was purchased from SPL Life Sciences (Pocheon, Gyeonggi-do, Korea). Magnetic particle concentrator was purchased from Dynal Inc. (Lake Success, NY, USA).
Preparation of immunomagnetic nanoparticles with antiCronobacter IgG
The polyclonal rabbit anti-Cronobacter IgG used in this study was prepared in the Laboratory of Food Safety and Microbiology, Yeungnam University, Republic of Korea, under Animal Ethics License No. 2013 -012 and 2012 -010 (Song et al., 2016 . The purified rabbit anti-Cronobacter IgG was conjugated to the carboxyl magnetic iron oxide nanoparticles according to the manufacturer's instruction and the method described in our previous study (Shukla et al., 2016a) . Briefly, 0.2 mL of the magnetic iron oxide nanoparticles (30 nm diameter) was added into a 1.5 mL eppendorf tube, after which 0.2 mL activation buffer was added to the magnetic iron oxide nanoparticles. Next, 100 mL of the EDAC/NHS (containing 0.5 mg/mL EDAC and 0.25 mg/mL NHS) solution was added into the magnetic iron oxide nanoparticles, mixed well, and allowed to react at room temperature for 5e10 min with continuous mixing. Next, 0.5 mL of coupling buffer was added to the activated magnetic iron oxide nanoparticles, mixed well, and amended with 0.5 mL of a various of concentrations of anti-Cronobacter IgG at 3.0 mg/mL, 3.4 mg/mL, and 4.0 mg/mL. The reactant of anti-Cronobacter IgG and magnetic iron oxide nanoparticles was then allowed to react at room temperature for 2 h with continuous mixing. The reactant was subsequently incubated for 10 min at room temperature after added with 10 mL quenching solution. Next, the reaction mixture was transferred into a disposable glass tube, after which 3 mL wash/storage solution was added, and the reactant was mixed gently. The disposable glass tube was then inserted into the magnetic particle concentrator, and the conjugated magnetic iron oxide nanoparticles were allowed to separate at 4 C for 4 h, after which the buffer was carefully transferred to a new disposable glass tube to check unconjugated anti-Cronobacter IgG. Finally, anti-Cronobacter IgG conjugated magnetic iron oxide nanoparticles were resuspended with 1 mL wash/storage buffer to store up to 3 months at 4 C. The conjugation of anti-Cronobacter IgG and magnetic nanoparticles was confirmed by measuring the average particle size change before and after conjugation (Jans et al., 2009; Chen et al., 2016) .
